BiomX Inc (AMEX:PHGE.U)
$ 0.9 -0.05 (-5.26%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 0.60 GF Score: 32/100

Biomx Inc Corporate Call Transcript

Feb 22, 2023 / 02:00PM GMT
Release Date Price: $2.5 (-17.90%)
Operator

Good morning and welcome to the BiomX conference call to discuss results from the company's ongoing Phase 1b/2a trial in cystic fibrosis. (Operator Instructions)

I would now like to turn the call over to Marina Wolfson, Chief Financial Officer of BiomX. Please proceed.

Marina Wolfson
BiomX Inc. - CFO

Thank you for joining us today to discuss the results from Part 1 of our ongoing Phase 1b/2a trial evaluating BX004 for the treatment of Pseudomonas aeruginosa infections in patients with cystic fibrosis or CF.

Earlier today, BiomX issued a press release detailing results from Part 1 of our study and became available just after 6:30 AM Eastern Time and can be found on our website at biomx.com. A replay of this call will be available on the Investors section of our website.

Before we begin, I'd like to review the Safe Harbor provision. All statements on this call that are not factual historic statements may be deemed forward-looking statements.

For instance, we're using forward-looking statements when we discuss in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot